Reduced production and release of Insuman Basal, Comb and Rapid insulin
Reduced production and release of Insuman Basal, Comb and Rapid insulin.
As a result of a problem with the manufacturing process of Insuman, the production and release of all batches of Insuman Basal, Comb and Rapid (cartridges and pre-filled pens) has been reduced. Insuman is a range of insulin-containing solutions and suspensions for injection.
The official announcement says that temporary supply disruptions are expected in Bulgaria, Czech Republic, Hungary, Norway and Poland while the issue is being addressed. However, IDDT has become aware of people in the UK obtaining their supplies of Insuman.
Healthcare Professionals in countries affected will be informed of the shortage by the company. In the instance of shortage, healthcare professionals are being advised to prescribe an alternative human insulin, taking into account local and national guidance. Healthcare Professionals should ensure that patients monitor their blood glucose closely during the switch to a different human insulin.
The shortage will not affect Insuman vials, Insuman Implantable vials, Infusat vials and Infusat cartridges.
For further information see European Medicines Agency (EMA) information sheet (PDF, 74KB)